132 related articles for article (PubMed ID: 10931382)
1. Interleukin-2-induced nitric oxide synthase and nuclear factor-kappaB activity in activated natural killer cells and the production of interferon-gamma.
Jyothi MD; Khar A
Scand J Immunol; 2000 Aug; 52(2):148-55. PubMed ID: 10931382
[TBL] [Abstract][Full Text] [Related]
2. The induction of nitric oxide by interleukin-12 and tumor necrosis factor-alpha in human natural killer cells: relationship with the regulation of lytic activity.
Salvucci O; Kolb JP; Dugas B; Dugas N; Chouaib S
Blood; 1998 Sep; 92(6):2093-102. PubMed ID: 9731067
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production.
Cifone MG; D'Alò S; Parroni R; Millimaggi D; Biordi L; Martinotti S; Santoni A
Blood; 1999 Jun; 93(11):3876-84. PubMed ID: 10339496
[TBL] [Abstract][Full Text] [Related]
4. Effect of redox modulation on xenogeneic target cells: the combination of nitric oxide and thiol deprivation protects porcine endothelial cells from lysis by IL-2-activated human NK cells.
Tsuyuki S; Horvath-Arcidiacono JA; Bloom ET
J Immunol; 2001 Mar; 166(6):4106-14. PubMed ID: 11238660
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta, inducible nitric oxide synthase, and nuclear factor-kappaB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-gamma injection.
Hartlage-Rübsamen M; Lemke R; Schliebs R
J Neurosci Res; 1999 Aug; 57(3):388-98. PubMed ID: 10412030
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its role in the elicitation of an effective antitumor immune response.
Jyothi MD; Khar A
Cancer Immunol Immunother; 2000 Dec; 49(10):563-72. PubMed ID: 11129327
[TBL] [Abstract][Full Text] [Related]
8. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
9. Cycloprodigiosin up-regulates inducible nitric oxide synthase gene expression in hepatocytes stimulated by interleukin-1beta.
Teshima S; Nakanishi H; Kamata K; Kaibori M; Kwon AH; Kamiyama Y; Nishizawa M; Ito S; Okumura T
Nitric Oxide; 2004 Aug; 11(1):9-16. PubMed ID: 15350552
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
[TBL] [Abstract][Full Text] [Related]
11. Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-kappaB activation by islets.
Blair LA; Heitmeier MR; Scarim AL; Maggi LB; Corbett JA
Diabetes; 2001 Feb; 50(2):283-90. PubMed ID: 11272138
[TBL] [Abstract][Full Text] [Related]
12. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB mediates simultaneous induction of inducible nitric-oxide synthase and Up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages.
Hammermann R; Dreissig MD; Mössner J; Fuhrmann M; Berrino L; Göthert M; Racké K
Mol Pharmacol; 2000 Dec; 58(6):1294-302. PubMed ID: 11093766
[TBL] [Abstract][Full Text] [Related]
14. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells.
Cifone MG; Festuccia C; Cironi L; Cavallo G; Chessa MA; Pensa V; Tubaro E; Santoni A
Cell Immunol; 1994 Aug; 157(1):181-94. PubMed ID: 7518750
[TBL] [Abstract][Full Text] [Related]
15. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
16. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
Hattori Y; Nakanishi N; Kasai K
Cardiovasc Res; 2002 Jun; 54(3):649-58. PubMed ID: 12031711
[TBL] [Abstract][Full Text] [Related]
17. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
[TBL] [Abstract][Full Text] [Related]
19. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB.
Iuvone T; D'Acquisto F; Van Osselaer N; Di Rosa M; Carnuccio R; Herman AG
Br J Pharmacol; 1998 Apr; 123(7):1325-30. PubMed ID: 9579726
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
